Are the epi-on and epi-off CXL protocols equivalent in the treatment of keratoconus?
Arch Soc Esp Oftalmol (Engl Ed)
.
2022 Mar;97(3):121-123.
doi: 10.1016/j.oftale.2022.01.002.
Epub 2022 Feb 10.
Authors
F D'Oria
1
,
J L Alio
2
Affiliations
1
Vissum Miranza, Alicante, Spain; Department of Basic Medical Science, Neuroscience and Sense Organs, Universidad de Bari, Bari, Italy.
2
Vissum Miranza, Alicante, Spain; División de Oftalmología, Universidad Miguel Hernández, Alicante, Spain. Electronic address: jlalio@vissum.com.
PMID:
35248392
DOI:
10.1016/j.oftale.2022.01.002
No abstract available
Publication types
Editorial
MeSH terms
Cross-Linking Reagents / therapeutic use
Humans
Keratoconus* / drug therapy
Riboflavin / therapeutic use
Substances
Cross-Linking Reagents
Riboflavin